FARA to FA Patients: Consider Enrolling in 3 Clinical Trials

FARA to FA Patients: Consider Enrolling in 3 Clinical Trials

296912

FARA to FA Patients: Consider Enrolling in 3 Clinical Trials

People with Friedreich’s ataxia (FA) are encouraged to enroll in three clinical trials evaluating the effects of dietary supplements on exercise, the safety and efficacy of the experimental therapy vatiquinone, and the utility of wearing sensors to monitor the disease’s progression and severity. The Friedreich’s Ataxia Research Alliance (FARA) listed the enrollment efforts for these studies, among other updates, in its monthly newsletter. “The enrolling clinical studies and trials are only possible through the collaborative…

You must be logged in to read/download the full post.